BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25813380)

  • 1. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.
    Campos D; Freitas D; Gomes J; Magalhães A; Steentoft C; Gomes C; Vester-Christensen MB; Ferreira JA; Afonso LP; Santos LL; Pinto de Sousa J; Mandel U; Clausen H; Vakhrushev SY; Reis CA
    Mol Cell Proteomics; 2015 Jun; 14(6):1616-29. PubMed ID: 25813380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
    Steentoft C; Vakhrushev SY; Joshi HJ; Kong Y; Vester-Christensen MB; Schjoldager KT; Lavrsen K; Dabelsteen S; Pedersen NB; Marcos-Silva L; Gupta R; Bennett EP; Mandel U; Brunak S; Wandall HH; Levery SB; Clausen H
    EMBO J; 2013 May; 32(10):1478-88. PubMed ID: 23584533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
    Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
    Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
    Schjoldager KT; Vakhrushev SY; Kong Y; Steentoft C; Nudelman AS; Pedersen NB; Wandall HH; Mandel U; Bennett EP; Levery SB; Clausen H
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9893-8. PubMed ID: 22566642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells.
    Vakhrushev SY; Steentoft C; Vester-Christensen MB; Bennett EP; Clausen H; Levery SB
    Mol Cell Proteomics; 2013 Apr; 12(4):932-44. PubMed ID: 23399548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth research of multidrug resistance related cell surface glycoproteome in gastric cancer.
    Li K; Sun Z; Zheng J; Lu Y; Bian Y; Ye M; Wang X; Nie Y; Zou H; Fan D
    J Proteomics; 2013 Apr; 82():130-40. PubMed ID: 23470797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.
    Yamamoto M; Takahashi T; Serada S; Sugase T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Naka T; Mori M; Doki Y
    Cancer Sci; 2017 Oct; 108(10):2052-2060. PubMed ID: 28746773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
    Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.
    Steentoft C; Fuhrmann M; Battisti F; Van Coillie J; Madsen TD; Campos D; Halim A; Vakhrushev SY; Joshi HJ; Schreiber H; Mandel U; Narimatsu Y
    Glycobiology; 2019 Apr; 29(4):307-319. PubMed ID: 30726901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.
    Bones J; Byrne JC; O'Donoghue N; McManus C; Scaife C; Boissin H; Nastase A; Rudd PM
    J Proteome Res; 2011 Mar; 10(3):1246-65. PubMed ID: 21142185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.
    Wu J; Qin H; Li T; Cheng K; Dong J; Tian M; Chai N; Guo H; Li J; You X; Dong M; Ye M; Nie Y; Zou H; Fan D
    Oncotarget; 2016 May; 7(18):25315-27. PubMed ID: 27015365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative mapping of the in vivo O-GalNAc glycoproteome in mouse tissues identifies GalNAc-T2 O-glycosites in metabolic disorder.
    Yang W; Tian E; Chernish A; McCluggage P; Dalal K; Lara A; Ten Hagen KG; Tabak LA
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303703120. PubMed ID: 37862385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
    Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
    J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
    Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
    J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery.
    Campos D; Freitas D; Gomes J; Reis CA
    Expert Rev Proteomics; 2015 Aug; 12(4):337-42. PubMed ID: 26098314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins.
    Vester-Christensen MB; Halim A; Joshi HJ; Steentoft C; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21018-23. PubMed ID: 24101494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer.
    Shekari N; Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Anticancer Agents Med Chem; 2019; 19(3):304-309. PubMed ID: 30543177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer.
    Hwang IR; Nahm DH; Cho SN; Longenecker BM; Rao Koganty R; Park IS
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):582-7. PubMed ID: 10473872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.